|
Market Closed -
Nasdaq
04:00:00 10/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 111.35 USD | +0.71% |
|
+6.80% | -0.05% |
| 10-10 | 'Surveillance Pricing' Comes Under Scrutiny | MT |
| 10-10 | FDA Center for Drug Evaluation & Research Issues Warning Letter to Walmart | CI |
Company Valuation: Walmart Inc.
Data adjusted to current consolidation scope
| Fiscal Period: January | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 387,816 | 387,989 | 444,892 | 788,557 | 949,566 | 883,423 | - | - |
| Change | - | 0.04% | 14.67% | 77.25% | 20.42% | -6.97% | - | - |
| Enterprise Value (EV) 1 | 415,887 | 423,986 | 481,916 | 825,310 | 990,362 | 934,700 | 935,487 | 937,301 |
| Change | - | 1.95% | 13.66% | 71.26% | 20% | -5.62% | 0.08% | 0.19% |
| P/E | 28.7x | 33.7x | 28.8x | 40.7x | 43.6x | 38.7x | 35x | 31.4x |
| PBR | 4.69x | 5.11x | 5.31x | 8.67x | 9.59x | 8.2x | 7.46x | 6.99x |
| PEG | - | -2.7x | 0.8x | 1.6x | 3.3x | 7.2x | 3.3x | 2.7x |
| Capitalization / Revenue | 0.68x | 0.64x | 0.69x | 1.17x | 1.34x | 1.17x | 1.12x | 1.07x |
| EV / Revenue | 0.73x | 0.7x | 0.75x | 1.22x | 1.4x | 1.24x | 1.19x | 1.14x |
| EV / EBITDA | 11.3x | 11.9x | 12.4x | 19.4x | 21.9x | 19x | 17.6x | 16.2x |
| EV / EBIT | 16x | 17.2x | 17.8x | 28x | 31.8x | 27.8x | 25.4x | 23x |
| EV / FCF | 37.6x | 35.4x | 31.9x | 65.2x | 66.4x | 79.5x | 58x | 50.8x |
| FCF Yield | 2.66% | 2.83% | 3.14% | 1.53% | 1.51% | 1.26% | 1.72% | 1.97% |
| Dividend per Share 2 | 0.7333 | 0.7467 | 0.76 | 0.83 | 0.94 | 0.9964 | 1.05 | 1.108 |
| Rate of return | 1.57% | 1.56% | 1.38% | 0.85% | 0.79% | 0.89% | 0.94% | 1% |
| EPS 2 | 1.623 | 1.423 | 1.913 | 2.41 | 2.73 | 2.877 | 3.179 | 3.542 |
| Distribution rate | 45.2% | 52.5% | 39.7% | 34.4% | 34.4% | 34.6% | 33% | 31.3% |
| Net sales 1 | 567,762 | 605,881 | 642,637 | 674,538 | 706,413 | 752,858 | 785,705 | 822,281 |
| EBITDA 1 | 36,708 | 35,547 | 38,865 | 42,477 | 45,185 | 49,157 | 53,269 | 57,770 |
| EBIT 1 | 26,050 | 24,602 | 27,012 | 29,504 | 31,096 | 33,658 | 36,815 | 40,716 |
| Net income 1 | 13,673 | 11,680 | 15,511 | 19,436 | 21,893 | 23,012 | 25,362 | 28,067 |
| Net Debt 1 | 28,071 | 35,997 | 37,024 | 36,753 | 40,796 | 51,277 | 52,064 | 53,879 |
| Reference price 2 | 46.60 | 47.96 | 55.08 | 98.16 | 119.14 | 111.35 | 111.35 | 111.35 |
| Nbr of stocks (in thousands) | 8,321,635 | 8,090,400 | 8,076,701 | 8,033,386 | 7,970,167 | 7,933,746 | - | - |
| Announcement Date | 17/2/22 | 21/2/23 | 20/2/24 | 20/2/25 | 19/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 38.71x | 1.24x | 19.01x | 0.89% | 883B | |
| 24.19x | 1.16x | 10.09x | 0.98% | 50.5B | |
| 16.01x | 0.57x | 8.21x | 3.22% | 41.58B | |
| 16.31x | 0.66x | 12.32x | 2.83% | 38.44B | |
| 21.33x | 0.9x | 6x | 5.93% | 36.28B | |
| 12.24x | 0.34x | 6.37x | 2.44% | 36.4B | |
| 27.04x | 0.84x | 9.7x | 2.73% | 33.68B | |
| 12.09x | 0.46x | 5.87x | 3.9% | 31.58B | |
| 20.82x | 0.77x | 6.42x | 1.25% | 26.52B | |
| 16.16x | 0.58x | 6.55x | 2.97% | 26.69B | |
| Average | 20.49x | 0.75x | 9.05x | 2.71% | 120.51B | |
| Weighted average by Cap. | 33.36x | 1.10x | 16.12x | 1.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WMT Stock
- Valuation Walmart Inc.
Select your edition
All financial news and data tailored to specific country editions
